Invivyd (IVVD) Net Cash Flow (QoQ) (2021 - 2025)
Invivyd (IVVD) Net Cash Flow (QoQ) (2021 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Nanobiotix | 1,792.52 Bn | 1,792.46 Bn | - |
| 2 | Akari Therapeutics | 999.95 Bn | 999.95 Bn | - |
| 3 | BeOne Medicines | 475.97 Bn | 471.17 Bn | 1.35 Bn |
| 4 | Vertex Pharmaceuticals | 124.91 Bn | 117.66 Bn | 2.59 Bn |
| 5 | Regeneron Pharmaceuticals | 72.31 Bn | 63.56 Bn | 3.31 Bn |
| 6 | Belite Bio | 62.01 Bn | 62.01 Bn | - |
| 7 | Argenx Se | 54.23 Bn | 49.04 Bn | 1.41 Bn |
| 8 | Alnylam Pharmaceuticals | 38.31 Bn | 35.30 Bn | 959.66 Mn |
| 9 | Revolution Medicines | 36.16 Bn | 36.16 Bn | - |
| 10 | Invivyd | 102.14 Mn | -124.55 Mn | 16.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 183.09% |
| Sep 30, 2025 | 479.80% |
| Jun 30, 2025 | 38.01% |
| Mar 31, 2025 | 43.34% |
| Dec 31, 2024 | 8.50% |
| Sep 30, 2024 | 1.19% |
| Jun 30, 2024 | -268.85% |
| Mar 31, 2024 | -159.80% |
| Dec 31, 2023 | -68.57% |
| Sep 30, 2023 | 1,422.91% |
| Jun 30, 2023 | -113.16% |
| Mar 31, 2023 | 118.49% |
| Dec 31, 2022 | 5.42% |
| Sep 30, 2022 | -243.13% |
| Jun 30, 2022 | -473.12% |
| Mar 31, 2022 | -115.64% |
| Dec 31, 2021 | -25.43% |
| Sep 30, 2021 | -71.53% |
| Jun 30, 2021 | 1,368.95% |